These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 2326543

  • 1. Enhancement of cisplatin toxicity by buthionine sulfoximine, a glutathione-depleting agent, in mice.
    Ishikawa M, Takayanagi Y, Sasaki K.
    Res Commun Chem Pathol Pharmacol; 1990 Jan; 67(1):131-41. PubMed ID: 2326543
    [Abstract] [Full Text] [Related]

  • 2. The deleterious effect of buthionine sulfoximine, a glutathione-depleting agent, on the cisplatin toxicity in mice.
    Ishikawa M, Takayanagi Y, Sasaki K.
    Jpn J Pharmacol; 1990 Apr; 52(4):652-5. PubMed ID: 2342233
    [Abstract] [Full Text] [Related]

  • 3. Influence of buthionine sulfoximine on the lethality of ifosfamide and ifosfamide-induced urotoxicity in mice.
    Ishikawa M, Takayanagi Y, Sasaki K.
    Res Commun Chem Pathol Pharmacol; 1989 Mar; 63(3):455-8. PubMed ID: 2727395
    [Abstract] [Full Text] [Related]

  • 4. Role of glutathione for cisplatin nephrotoxicity in young and adult rats.
    Appenroth D, Winnefeld K.
    Ren Fail; 1993 Mar; 15(2):135-9. PubMed ID: 8469780
    [Abstract] [Full Text] [Related]

  • 5. Nephrotoxicity of thiazoles structurally related to thiabendazole in mice depleted of glutathione by treatment with buthionine sulfoximine.
    Mizutani T, Yoshida K, Ito K.
    Res Commun Chem Pathol Pharmacol; 1992 Jan; 75(1):29-38. PubMed ID: 1626124
    [Abstract] [Full Text] [Related]

  • 6. Effects of buthionine sulfoximine on the nephrotoxicity of 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea (MeCCNU).
    Kramer RA, Schuller HM, Smith AC, Boyd MR.
    J Pharmacol Exp Ther; 1985 Aug; 234(2):498-506. PubMed ID: 4020683
    [Abstract] [Full Text] [Related]

  • 7. Protection against cisplatin toxicity by administration of glutathione ester.
    Anderson ME, Naganuma A, Meister A.
    FASEB J; 1990 Nov; 4(14):3251-5. PubMed ID: 2227215
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics of buthionine sulfoximine (NSC 326231) and its effect on melphalan-induced toxicity in mice.
    Smith AC, Liao JT, Page JG, Wientjes MG, Grieshaber CK.
    Cancer Res; 1989 Oct 01; 49(19):5385-91. PubMed ID: 2766304
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of cisplatin-induced nephrotoxicity in rats by buthionine sulfoximine, a glutathione synthesis inhibitor.
    Mayer RD, Lee KE, Cockett AT.
    Cancer Chemother Pharmacol; 1987 Oct 01; 20(3):207-10. PubMed ID: 2890443
    [Abstract] [Full Text] [Related]

  • 10. Pharmacologic modulation of reduced glutathione circadian rhythms with buthionine sulfoximine: relationship with cisplatin toxicity in mice.
    Li XM, Metzger G, Filipski E, Boughattas N, Lemaigre G, Hecquet B, Filipski J, Levi F.
    Toxicol Appl Pharmacol; 1997 Apr 01; 143(2):281-90. PubMed ID: 9144445
    [Abstract] [Full Text] [Related]

  • 11. [Increasing chemosensitivity to cisplatin by glutathione depletion with buthionine sulfoximine. In vitro and in vivo studies with a human squamous cell cancer line].
    Bier H.
    Laryngorhinootologie; 1990 Jan 01; 69(1):16-20. PubMed ID: 2310456
    [Abstract] [Full Text] [Related]

  • 12. Long-term buthionine-sulfoximine-mediated toxicity in cultured hepatoma cell lines.
    Dierickx PJ.
    Res Commun Chem Pathol Pharmacol; 1990 Mar 01; 67(3):423-6. PubMed ID: 2160706
    [Abstract] [Full Text] [Related]

  • 13. Effects of phorone and/or buthionine sulfoximine on teratogenicity of 5-fluorouracil in mice.
    Naya M, Mataki Y, Takahira H, Deguchi T, Yasuda M.
    Teratology; 1990 Mar 01; 41(3):275-80. PubMed ID: 2326751
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Menthofuran-dependent and independent aspects of pulegone hepatotoxicity: roles of glutathione.
    Thomassen D, Slattery JT, Nelson SD.
    J Pharmacol Exp Ther; 1990 May 01; 253(2):567-72. PubMed ID: 2338648
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Lack of enhanced myelotoxicity with buthionine sulfoximine and sulfhydryl-dependent anticancer agents in mice.
    Soble MJ, Dorr RT.
    Res Commun Chem Pathol Pharmacol; 1987 Feb 01; 55(2):161-80. PubMed ID: 3823607
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.